May 4 Rexahn Pharmaceuticals Inc:
* Rexahn Pharmaceuticals reports first quarter 2017 financial results and provides corporate update
* Q1 loss per share $0.09
* Q1 earnings per share view $-0.02 -- Thomson Reuters I/B/E/S
* Rexahn Pharmaceuticals - expects its current cash and investments will be sufficient to fund cash flow requirements for current activities into mid-2018 Source text for Eikon: Further company coverage:
GLOBAL MARKETS-Asia stocks edge up on optimism over global growth, dollar soft
TOKYO, June 26 Asian shares edged up on Monday on optimism for global growth, while the dollar was on the defensive as a subdued U.S. inflation outlook capped U.S. bond yields and raised questions about the Federal Reserve's plans to tighten policy.